Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Aripiprazole-induced parkinsonism and its association with dopamine and serotonin receptor polymorphisms.

Journal of clinical psychopharmacology - 1 Jun 2008

López-Torres Enrique, Salomón Jesús, Vicario Francis, Peñas-Lledó Eva, Dorado Pedro, Llerena Adrián

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antipsychotic Agents
Share to Drug Administration Schedule
Share to Parkinsonian Disorders
Share to Piperazines

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Psychotic Disorders

Share to Quinolones

Share to Receptor, Serotonin, 5-HT2A

Share to Receptors, Dopamine D2

Source

Identifiers

PMID: 18480698
DOI: 10.1097/JCP.0b013e318172757f

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Aripiprazole-induced parkinsonism and its association with dopamine and serotonin receptor polymorphisms.PMID 18480698Read ↗

Antipsychotic drug—aripiprazole against schizophrenia, its therapeutic and metabolic effects associated with gene polymorphismsSemantic proximity Read ↗

Parkinson’s Disease Pharmacogenomics: New Findings and PerspectivesSemantic proximity Read ↗

Candidate Genes Encoding Dopamine Receptors as Predictors of the Risk of Antipsychotic-Induced Parkinsonism and Tardive Dyskinesia in Schizophrenic PatientsSemantic proximity Read ↗

Secular trends of incidence and prevalence of parkinsonism and subtypes: A cohort study in the United KingdomSemantic proximity Read ↗

Dopaminergic Pathway Genes Influence Adverse Events Related to Dopaminergic Treatment in Parkinson's DiseaseSemantic proximity Read ↗

Clinical and Clinical-Pharmacogenetic Models for Prediction of the Most Common Psychiatric Complications Due to Dopaminergic Treatment in Parkinson's Disease.Semantic proximity Read ↗

Polymorphisms in candidate genes: implications for the current treatment of Parkinson's disease.Semantic proximity Read ↗

Safety and cardiovascular effects of multiple-dose administration of aripiprazole and olanzapine in a randomised clinical trialSemantic proximity Read ↗

Dopamine receptors and BDNF-haplotypes predict dyskinesia in Parkinson's diseaseSemantic proximity Read ↗

A Preliminary Investigation of Genetic Variants Linked to Aripiprazole-Induced Adverse EffectsSemantic proximity Read ↗

Taq1A polymorphism in the dopamine D2 receptor gene as a predictor of clinical response to aripiprazole.Semantic proximity Read ↗

Vitamin D receptor polymorphisms and the susceptibility of Parkinson’s diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.